Search

Your search keyword '"R. Rampal"' showing total 126 results

Search Constraints

Start Over You searched for: Author "R. Rampal" Remove constraint Author: "R. Rampal"
126 results on '"R. Rampal"'

Search Results

1. P1063: EFFICACY AND SAFETY OF PARSACLISIB-RUXOLITINIB COMBINATION THERAPY IN MYELOFIBROSIS PATIENTS WITH LOW VS HIGHER BASELINE PLATELET COUNT: A SUBGROUP ANALYSIS OF DATA FROM A PHASE 2 STUDY

3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

4. Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre observational study

5. The effect of climate change on the resilience of ecosystems with adaptive spatial pattern formation

6. PS1467 EARLY RESULTS OF A PHASE II STUDY OF COMBINED RUXOLITINIB AND THALIDOMIDE IN PATIENTS WITH MYELOFIBROSIS

7. Worldwide trends in blood pressure from 1975 to 2015:a pooled analysis of 1479 population-based measurement studies with 19.1 million participants

8. P027 Vitamin A modulates mucosal inflammation by augmenting Th1/Th17 differentiation in inflammatory bowel disease

9. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants

10. A century of trends in adult human height

11. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants

12. Professionals in search of professionalism: Journalists' dilemma in four Maghreb states

14. Uncertainty-dampening methods for reducing MRP system nervousness

15. Press and Political Liberalization in Taiwan

16. Post-martial law media boom in Taiwan

17. Credibility of the Asian News Broadcasts of the Voice of America and the British Broadcasting Corporation

18. Media, Sex, Violence, and Drugs in the Global Village

23. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

24. A century of trends in adult human height

25. Selinexor plus ruxolitinib in JAK inhibitor treatment-naïve myelofibrosis: SENTRY Phase 3 study design.

26. Evaluation of long-term outcome following therapeutic mammaplasty: the effect of wound complication on initiation of adjuvant therapy and subsequent oncological outcome.

27. Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety.

28. Three and twelve-month analysis of the PROM-Q study: comparison of patient-reported outcome measures using the BREAST-Q questionnaire in pre- vs. sub-pectoral implant-based immediate breast reconstruction.

29. Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.

30. Burden of Pneumococcal Disease in Young Children Due to Serotypes Contained in Different Pneumococcal Conjugate Vaccines in Eight Asian Countries and Territories.

31. Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.

32. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.

34. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.

35. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.

36. Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy.

37. CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.

38. Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.

39. Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia.

40. Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

41. Can molecular insights guide treatment of AML evolved from MPNs?

42. The Prevalence and Antimicrobial Susceptibility Pattern of Gram-Positive Pathogens: Three-Year Study at a Tertiary Care Hospital in Mumbai, India.

43. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease.

44. Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNγ Production.

45. Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.

46. In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital.

47. Single-cell mutation analysis of clonal evolution in myeloid malignancies.

48. Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.

49. Survival following allogeneic transplant in patients with myelofibrosis.

50. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.

Catalog

Books, media, physical & digital resources